FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 131 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $802,000 | +137.3% | 47,157 | +86.9% | 0.00% | 0.0% |
| Q1 2019 | $338,000 | +45.7% | 25,229 | +1.2% | 0.00% | – |
| Q4 2018 | $232,000 | -32.6% | 24,929 | +0.8% | 0.00% | -100.0% |
| Q3 2018 | $344,000 | -11.3% | 24,729 | +0.8% | 0.00% | 0.0% |
| Q2 2018 | $388,000 | -6.7% | 24,529 | +1.2% | 0.00% | 0.0% |
| Q1 2018 | $416,000 | +65.1% | 24,229 | +110.7% | 0.00% | – |
| Q4 2017 | $252,000 | -59.0% | 11,500 | -22.3% | 0.00% | -100.0% |
| Q4 2015 | $614,000 | +39.5% | 14,800 | -48.3% | 0.00% | 0.0% |
| Q3 2015 | $440,000 | -37.0% | 28,600 | +1.8% | 0.00% | 0.0% |
| Q2 2015 | $698,000 | +8.7% | 28,100 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $642,000 | +23.9% | 28,100 | +46.4% | 0.00% | 0.0% |
| Q4 2014 | $518,000 | – | 19,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|